Get my own profile
Public access
View all73 articles
2 articles
available
not available
Based on funding mandates
Co-authors
Irene GhobrialDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Aldo RoccaroASST Spedali Civili di Brescia, Brescia, ItalyVerified email at asst-spedalicivili.it
Barbara MuzSenior Scientist, WUGENVerified email at wugen.com
Pilar de la PuenteSanford Research. Cancer Biology and ImmunotherapiesVerified email at sanfordhealth.org
Charles LinMassachusetts General Hospital, Harvard Medical SchoolVerified email at hms.harvard.edu
Michaela ReaganMaine Health Institute for ResearchVerified email at mainehealth.org
Noha Nabil SalamaCairo University Faculty of Pharmacy and St. Louis College of PharmacyVerified email at pharma.cu.edu.eg
Samuel AchilefuUniversity of Texas Southwestern Medical Center, DallasVerified email at UTSouthwestern.edu
Kinan AlhallakNortheastern UniversityVerified email at northeastern.edu
Abraham (Avri) RubinsteinProfessor of Phramceutical Sciences, The Hebrew University of JerusalemVerified email at ekmd.huji.ac.il
James D GriffinDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
Michele Moschetta, MD PhDExecutive Director, Early Clinical Development Oncology, AstraZenecaVerified email at astrazeneca.com
Follow
Abdel Kareem Azab
Associate Professor, Biomedical Engineering, University of Texas Southwestern Medical Center
Verified email at utsouthwestern.edu - Homepage